--- title: "TNF Pharmaceuticals (now Q/C Technologies) gets Nasdaq minimum bid notice" url: "https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-gets-nasdaq-minimum-bid/" publisher: "aibio.space (Biotech Investor Relations News)" date: "2025-03-21" section: "Listings" tickers: "NASDAQ:QCLS" source: "https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/form8-k.htm" summary: "TNF Pharmaceuticals, now Q/C Technologies, has until September 15, 2025 to bring its closing bid price back to $1.00 for ten business days." --- By the aibio.space news desk. Sources - [Q/C Technologies, Inc. 8-K (2025-03-21)](https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/form8-k.htm) [QCLS](https://aibio.space/companies/q-c-technologies/) 2025-03-21 # TNF Pharmaceuticals (now Q/C Technologies) gets Nasdaq minimum bid notice Tickers [QCLS](https://aibio.space/companies/q-c-technologies/) TNF Pharmaceuticals, now Q/C Technologies, has until September 15, 2025 to bring its closing bid price back to $1.00 for ten business days. ## Key facts - **Company**: Q/C Technologies, Inc. (NASDAQ: QCLS) - **News type**: Listings - **Primary source**: [Q/C Technologies, Inc. 8-K (2025-03-21)](https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/form8-k.htm) *Stone columns of a government building. Photo: The Building Envelope, CC0, via StockSnap. The picture shows the field, not the companies named.* TNF Pharmaceuticals, Inc. (now Q/C Technologies, Inc.) said it received a letter on March 17, 2025 from the Listing Qualifications Department of the Nasdaq Stock Market. The letter said the company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). Nasdaq based its notice on the closing bid price of the common stock for the 30 consecutive business days between January 30, 2025, to March 14, 2025. The company has a compliance period of 180 calendar days, or until September 15, 2025, under Nasdaq Listing Rule 5810(c)(3)(A). To regain compliance, the stock must close at $1.00 or more for at least ten consecutive business days during that period. If it does not regain compliance in time, the company may be eligible for an additional 180 calendar days. To qualify, it must meet the market value of publicly held shares requirement and the other initial listing standards of The Nasdaq Capital Market, except the bid price rule. It must also give written notice that it intends to cure the deficiency, by a reverse stock split if necessary. The letter has no immediate impact on the listing, and at the time the stock traded under the symbol TNFA. If Nasdaq later moves to delist the stock, the company may appeal. The notice is in the company's [8-K filing](https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/form8-k.htm). [Report an error](https://aibio.space/reputation/#correction) ## Companies in this story QCLS Q/C Technologies, Inc. NASDAQ ยท United States Open the starter desk ## More in Listings Listings ### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/) Oct 29, 2026 Listings ### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/) Oct 29, 2026 Listings ### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/) Oct 28, 2026 --- Source page: https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-gets-nasdaq-minimum-bid/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TNF Pharmaceuticals (now Q/C Technologies) gets Nasdaq minimum bid notice", 2025-03-21, https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-gets-nasdaq-minimum-bid/